Framke E, Thygesen LC, Malmborg M, Schou M, et al. Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark. Mult Scler 2024 Jan 11:13524585231221415. doi: 10.1177/13524585231221415.
PMID: 38205784